280 related articles for article (PubMed ID: 31815915)
1. Dexpramipexole blocks Nav1.8 sodium channels and provides analgesia in multiple nociceptive and neuropathic pain models.
Urru M; Muzzi M; Coppi E; Ranieri G; Buonvicino D; Camaioni E; Coppini R; Pugliese AM; Tanaka B; Estacion M; Waxman SG; Dib-Hajj SD; Chiarugi A
Pain; 2020 Apr; 161(4):831-841. PubMed ID: 31815915
[TBL] [Abstract][Full Text] [Related]
2. The Natural Flavonoid Naringenin Elicits Analgesia through Inhibition of NaV1.8 Voltage-Gated Sodium Channels.
Zhou Y; Cai S; Moutal A; Yu J; Gómez K; Madura CL; Shan Z; Pham NYN; Serafini MJ; Dorame A; Scott DD; François-Moutal L; Perez-Miller S; Patek M; Khanna M; Khanna R
ACS Chem Neurosci; 2019 Dec; 10(12):4834-4846. PubMed ID: 31697467
[TBL] [Abstract][Full Text] [Related]
3. Discovery and biological evaluation of 5-aryl-2-furfuramides, potent and selective blockers of the Nav1.8 sodium channel with efficacy in models of neuropathic and inflammatory pain.
Kort ME; Drizin I; Gregg RJ; Scanio MJ; Shi L; Gross MF; Atkinson RN; Johnson MS; Pacofsky GJ; Thomas JB; Carroll WA; Krambis MJ; Liu D; Shieh CC; Zhang X; Hernandez G; Mikusa JP; Zhong C; Joshi S; Honore P; Roeloffs R; Marsh KC; Murray BP; Liu J; Werness S; Faltynek CR; Krafte DS; Jarvis MF; Chapman ML; Marron BE
J Med Chem; 2008 Feb; 51(3):407-16. PubMed ID: 18176998
[TBL] [Abstract][Full Text] [Related]
4. Unique electrophysiological property of a novel Nav1.7, Nav1.8, and Nav1.9 sodium channel blocker, ANP-230.
Kamei T; Kudo T; Yamane H; Ishibashi F; Takada Y; Honda S; Maezawa Y; Ikeda K; Oyamada Y
Biochem Biophys Res Commun; 2024 Aug; 721():150126. PubMed ID: 38776832
[TBL] [Abstract][Full Text] [Related]
5. DRG Voltage-Gated Sodium Channel 1.7 Is Upregulated in Paclitaxel-Induced Neuropathy in Rats and in Humans with Neuropathic Pain.
Li Y; North RY; Rhines LD; Tatsui CE; Rao G; Edwards DD; Cassidy RM; Harrison DS; Johansson CA; Zhang H; Dougherty PM
J Neurosci; 2018 Jan; 38(5):1124-1136. PubMed ID: 29255002
[TBL] [Abstract][Full Text] [Related]
6. Antidepressants inhibit Na
Horishita T; Yanagihara N; Ueno S; Okura D; Horishita R; Minami T; Ogata Y; Sudo Y; Uezono Y; Sata T; Kawasaki T
Naunyn Schmiedebergs Arch Pharmacol; 2017 Dec; 390(12):1255-1270. PubMed ID: 28905186
[TBL] [Abstract][Full Text] [Related]
7. Modulation of peripheral Na(+) channels and neuronal firing by n-butyl-p-aminobenzoate.
Thériault O; Poulin H; Sculptoreanu A; de Groat WC; O'Leary ME; Chahine M
Eur J Pharmacol; 2014 Mar; 727():158-66. PubMed ID: 24486399
[TBL] [Abstract][Full Text] [Related]
8. The roles of sodium channels in nociception: implications for mechanisms of neuropathic pain.
Liu M; Wood JN
Pain Med; 2011 Jul; 12 Suppl 3():S93-9. PubMed ID: 21752183
[TBL] [Abstract][Full Text] [Related]
9. Increased Resurgent Sodium Currents in Nav1.8 Contribute to Nociceptive Sensory Neuron Hyperexcitability Associated with Peripheral Neuropathies.
Xiao Y; Barbosa C; Pei Z; Xie W; Strong JA; Zhang JM; Cummins TR
J Neurosci; 2019 Feb; 39(8):1539-1550. PubMed ID: 30617209
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic Characterization of AMG8379, a Potent and Selective Small Molecule Sulfonamide Antagonist of the Voltage-Gated Sodium Channel Na
Kornecook TJ; Yin R; Altmann S; Be X; Berry V; Ilch CP; Jarosh M; Johnson D; Lee JH; Lehto SG; Ligutti J; Liu D; Luther J; Matson D; Ortuno D; Roberts J; Taborn K; Wang J; Weiss MM; Yu V; Zhu DXD; Fremeau RT; Moyer BD
J Pharmacol Exp Ther; 2017 Jul; 362(1):146-160. PubMed ID: 28473457
[TBL] [Abstract][Full Text] [Related]
11. A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat.
Jarvis MF; Honore P; Shieh CC; Chapman M; Joshi S; Zhang XF; Kort M; Carroll W; Marron B; Atkinson R; Thomas J; Liu D; Krambis M; Liu Y; McGaraughty S; Chu K; Roeloffs R; Zhong C; Mikusa JP; Hernandez G; Gauvin D; Wade C; Zhu C; Pai M; Scanio M; Shi L; Drizin I; Gregg R; Matulenko M; Hakeem A; Gross M; Johnson M; Marsh K; Wagoner PK; Sullivan JP; Faltynek CR; Krafte DS
Proc Natl Acad Sci U S A; 2007 May; 104(20):8520-5. PubMed ID: 17483457
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Nav1.7 channel by a novel blocker QLS-81 for alleviation of neuropathic pain.
Niu HL; Liu YN; Xue DQ; Dong LY; Liu HJ; Wang J; Zheng YL; Zou AR; Shao LM; Wang K
Acta Pharmacol Sin; 2021 Aug; 42(8):1235-1247. PubMed ID: 34103689
[TBL] [Abstract][Full Text] [Related]
13. Functional up-regulation of Nav1.8 sodium channel on dorsal root ganglia neurons contributes to the induction of scorpion sting pain.
Ye P; Hua L; Jiao Y; Li Z; Qin S; Fu J; Jiang F; Liu T; Ji Y
Acta Biochim Biophys Sin (Shanghai); 2016 Feb; 48(2):132-44. PubMed ID: 26764239
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-30b regulates expression of the sodium channel Nav1.7 in nerve injury-induced neuropathic pain in the rat.
Shao J; Cao J; Wang J; Ren X; Su S; Li M; Li Z; Zhao Q; Zang W
Mol Pain; 2016; 12():. PubMed ID: 27765894
[TBL] [Abstract][Full Text] [Related]
15.
Zhang F; Zhang C; Xu X; Zhang Y; Gong X; Yang Z; Zhang H; Tang D; Liang S; Liu Z
J Biol Chem; 2019 May; 294(18):7324-7334. PubMed ID: 30804211
[TBL] [Abstract][Full Text] [Related]
16. Pain without nociceptors? Nav1.7-independent pain mechanisms.
Minett MS; Falk S; Santana-Varela S; Bogdanov YD; Nassar MA; Heegaard AM; Wood JN
Cell Rep; 2014 Jan; 6(2):301-12. PubMed ID: 24440715
[TBL] [Abstract][Full Text] [Related]
17. Discovery of a selective, state-independent inhibitor of Na
Pajouhesh H; Beckley JT; Delwig A; Hajare HS; Luu G; Monteleone D; Zhou X; Ligutti J; Amagasu S; Moyer BD; Yeomans DC; Du Bois J; Mulcahy JV
Sci Rep; 2020 Sep; 10(1):14791. PubMed ID: 32908170
[TBL] [Abstract][Full Text] [Related]
18. Examination of the contribution of Nav1.7 to axonal propagation in nociceptors.
Goodwin G; McMurray S; Stevens EB; Denk F; McMahon SB
Pain; 2022 Jul; 163(7):e869-e881. PubMed ID: 34561392
[TBL] [Abstract][Full Text] [Related]
19. Antinociceptive properties of an isoform-selective inhibitor of Nav1.7 derived from saxitoxin in mouse models of pain.
Beckley JT; Pajouhesh H; Luu G; Klas S; Delwig A; Monteleone D; Zhou X; Giuvelis D; Meng ID; Yeomans DC; Hunter JC; Mulcahy JV
Pain; 2021 Apr; 162(4):1250-1261. PubMed ID: 33086288
[TBL] [Abstract][Full Text] [Related]
20. A disubstituted succinamide is a potent sodium channel blocker with efficacy in a rat pain model.
Priest BT; Garcia ML; Middleton RE; Brochu RM; Clark S; Dai G; Dick IE; Felix JP; Liu CJ; Reiseter BS; Schmalhofer WA; Shao PP; Tang YS; Chou MZ; Kohler MG; Smith MM; Warren VA; Williams BS; Cohen CJ; Martin WJ; Meinke PT; Parsons WH; Wafford KA; Kaczorowski GJ
Biochemistry; 2004 Aug; 43(30):9866-76. PubMed ID: 15274641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
